Home » Market News » DirectorsTalk Highlights » Advanced Oncotherapy Rapidly changing to commercial execution
Hardman & Co

Advanced Oncotherapy Rapidly changing to commercial execution

Advanced Oncotherapy plc (LON:AVO) is the topic of discussion when Dr Martin Hall Analyst at Hardman & Co joins DirectorsTalk. Martin talks us through the interesting developments being made at the company, commercial deals, brings us up to date with the LIGHT system and tells us his overall conclusion from his report and the company as an investment case.

Advanced Oncotherapy is a UK-based company focused on delivering a cost-effective proton-based radiotherapy solution called LIGHT. Based on ground-breaking technology developed and tested at world renowned CERN in Switzerland, the LIGHT system delivers an integrated proton radiotherapy system to treat cancer.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.